Feasibility of Discontinuation of Bruton's Tyrosine Kinase Inhibitors in Patients with Chronic Lymphocytic Leukemia: A Patient Survey

被引：0

作者：

Stephens, Deborah M. ^{[1
]}

Stewart, Chris ^{[2
]}

Avruch, Liza ^{[2
]}

Coombs, Catherine C. ^{[3
]}

Danilov, Alexey ^{[4
]}

Hill, Brian T. ^{[5
]}

Shadman, Mazyar ^{[6
]}

Gerrie, Alina S. ^{[7
]}

Jensen, Christopher E. ^{[1
]}

Hoffmann, Marc ^{[8
]}

Winter, Allison M. ^{[9
]}

Ermann, Daniel A. ^{[10
]}

Barr, Paul M. ^{[11
]}

O'Brien, Susan M. ^{[12
]}

Koffman, Brian ^{[2
]}

Byrd, John C. ^{[13
]}

机构：

[1] Univ North Carolina, Chapel Hill, NC USA

[2] CLL Soc, Chula Vista, CA USA

[3] Univ Calif Irvine Hlth, Orange, CA USA

[4] City Hope Comprehens Canc Ctr, Duarte, CA USA

[5] Cleveland Clin Fdn, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH USA

[6] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[7] Univ British Columbia, Div Med Oncol, Vancouver, BC, Canada

[8] Univ Kansas, Med Ctr, Kansas City, KS USA

[9] Cleveland Clin, Cleveland, OH USA

[10] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[11] Univ Rochester, Wilmot Canc Inst, Med Ctr, Rochester, NY USA

[12] UC Irvine, Chao Family Comprehens Canc Ctr, Orange, CA USA

[13] Univ Cincinnati, Dept Internal Med, Cincinnati, OH USA

来源：

关键词：

D O I：

10.1182/blood-2024-193298

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：7743 / 7745

页数：3